RAS突变-话题@MedSci

#RAS突变#

56篇内容 | 1904人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1585320, encodeId=47a3158532058, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=贝伐珠单抗联合FOLFOX，提高RAS突变型肠癌肝转移切除率, objectType=article, longId=181068, objectId=1eae18106814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eae18106814, replyNumber=0, likeNumber=96, createdTime=2019-10-15, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eae18106814, moduleTitle=贝伐珠单抗联合FOLFOX，提高RAS突变型肠癌肝转移切除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eae18106814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585319, encodeId=823b158531943, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, objectType=article, longId=179432, objectId=0a3e1e94321f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a3e1e94321f, replyNumber=0, likeNumber=77, createdTime=2019-09-15, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a3e1e94321f, moduleTitle=Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a3e1e94321f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585318, encodeId=d67f158531862, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=针对KRAS突变驱动的癌症疫苗, objectType=article, longId=177310, objectId=f1711e73100d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1711e73100d, replyNumber=0, likeNumber=95, createdTime=2019-08-10, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1711e73100d, moduleTitle=针对KRAS突变驱动的癌症疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1711e73100d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585317, encodeId=ae5a158531eb3, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破, objectType=article, longId=167693, objectId=bf9916e693b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf9916e693b0, replyNumber=0, likeNumber=71, createdTime=2019-06-06, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf9916e693b0, moduleTitle=Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf9916e693b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585316, encodeId=568e1585316b2, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一, objectType=article, longId=163057, objectId=c6f416305ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f416305ec3, replyNumber=0, likeNumber=59, createdTime=2019-03-28, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f416305ec3, moduleTitle=Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f416305ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585315, encodeId=bf2c1585315af, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, objectType=article, longId=162939, objectId=156a1629396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=156a1629396a, replyNumber=0, likeNumber=38, createdTime=2019-03-26, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=156a1629396a, moduleTitle=Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=156a1629396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585314, encodeId=3b6d1585314af, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！, objectType=article, longId=160958, objectId=d15316095898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15316095898, replyNumber=0, likeNumber=63, createdTime=2019-02-25, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15316095898, moduleTitle=Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d15316095898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585313, encodeId=6c9f15853134d, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？, objectType=article, longId=159865, objectId=7f2d1598656e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2d1598656e, replyNumber=0, likeNumber=86, createdTime=2019-02-14, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2d1598656e, moduleTitle=JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f2d1598656e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585312, encodeId=f2b2158531254, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法, objectType=article, longId=159572, objectId=4fbc1595e2df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbc1595e2df, replyNumber=0, likeNumber=72, createdTime=2019-02-08, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbc1595e2df, moduleTitle=ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbc1595e2df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585311, encodeId=474915853111f, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移, objectType=article, longId=156369, objectId=cc76156369d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc76156369d4, replyNumber=0, likeNumber=73, createdTime=2018-12-23, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc76156369d4, moduleTitle=Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc76156369d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585310, encodeId=1d0815853104d, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CANCER RES：Refametinib联合Sorafenib治疗RAS突变肝细胞癌, objectType=article, longId=151602, objectId=5b85151602b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b85151602b8, replyNumber=0, likeNumber=70, createdTime=2018-10-24, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b85151602b8, moduleTitle=CLIN CANCER RES：Refametinib联合Sorafenib治疗RAS突变肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b85151602b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585309, encodeId=ab07158530972, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=ANN ONCOL：转移性结直肠癌患者循环肿瘤DNA RAS突变分析, objectType=article, longId=140187, objectId=66ee14018e7e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66ee14018e7e, replyNumber=0, likeNumber=93, createdTime=2018-06-08, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66ee14018e7e, moduleTitle=ANN ONCOL：转移性结直肠癌患者循环肿瘤DNA RAS突变分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66ee14018e7e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585308, encodeId=632e15853087c, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义, objectType=article, longId=134277, objectId=24ab1342e7a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24ab1342e7a2, replyNumber=0, likeNumber=83, createdTime=2018-04-06, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24ab1342e7a2, moduleTitle=CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24ab1342e7a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585307, encodeId=8d74158530e80, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CANCER RES：乙酰水杨酸联合索拉非尼治疗RAS突变肿瘤, objectType=article, longId=131754, objectId=e271131e54a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e271131e54a4, replyNumber=0, likeNumber=71, createdTime=2018-03-09, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e271131e54a4, moduleTitle=CLIN CANCER RES：乙酰水杨酸联合索拉非尼治疗RAS突变肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e271131e54a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585306, encodeId=a7991585306b3, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=EUR J Cancer：转移性结直肠癌治疗中，BRAF和RAS突变对一线疗法（FOLFIRI加西妥昔单抗，FOLFIRI加贝伐单抗）的影响, objectType=article, longId=125177, objectId=1e501251e7c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e501251e7c5, replyNumber=0, likeNumber=122, createdTime=2018-01-01, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e501251e7c5, moduleTitle=EUR J Cancer：转移性结直肠癌治疗中，BRAF和RAS突变对一线疗法（FOLFIRI加西妥昔单抗，FOLFIRI加贝伐单抗）的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e501251e7c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585305, encodeId=34b015853055d, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）, objectType=article, longId=124481, objectId=c81c12448125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c81c12448125, replyNumber=0, likeNumber=52, createdTime=2017-12-26, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c81c12448125, moduleTitle=EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c81c12448125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585304, encodeId=0189158530489, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=Autophagy：RAS突变如何促进癌症发展, objectType=article, longId=124465, objectId=638712446549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638712446549, replyNumber=0, likeNumber=0, createdTime=2017-12-26, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638712446549, moduleTitle=Autophagy：RAS突变如何促进癌症发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638712446549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585303, encodeId=ef55158530301, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗, objectType=article, longId=123335, objectId=b8531233359c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8531233359c, replyNumber=0, likeNumber=59, createdTime=2017-12-15, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8531233359c, moduleTitle=张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8531233359c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585302, encodeId=3150158530227, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌, objectType=article, longId=121369, objectId=ea411213694d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea411213694d, replyNumber=0, likeNumber=0, createdTime=2017-11-27, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea411213694d, moduleTitle=CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea411213694d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1585301, encodeId=9cc71585301f0, content=<a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突变#</a>, objectTitle=ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存, objectType=article, longId=114633, objectId=757411463395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=757411463395, replyNumber=0, likeNumber=64, createdTime=2017-09-30, rootId=0, userName=bioon7, userId=6f2c17156536, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=757411463395, moduleTitle=ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=757411463395)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RAS突变

2020-05-29

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

贝伐珠单抗联合FOLFOX，提高RAS突变型肠癌肝转移切除率

2019-10-15

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Clinica Chimica Acta：利用改进的野生型阻断剂可在单管中敏感、选择性地检测密码子12和13 KRAS突变

2019-09-15

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

针对KRAS突变驱动的癌症疫苗

2019-08-10

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Amgen的AMG 510在KRAS突变的非小细胞肺癌I期临床实现突破

2019-06-06

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Cell Metab:糖真的有毒！高血糖环境下，胰腺细胞中致癌的KRAS突变暴增，或为导致胰腺癌的罪魁祸首之一

2019-03-28

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Sci Transl Med:KRAS突变型肺癌或喜迎MEK抑制剂联合用药

2019-03-26

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Cell:华人大拿再发力，揭秘NRAS突变黑色素瘤新机制！

2019-02-25

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

JTO：病例分享——见微知著，KRAS突变肺腺癌转化为小细胞肺癌是免疫治疗的耐药机制？

2019-02-14

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

ARCH PATHOL LAB MED：肺癌，结直肠癌和胰腺癌组织和血浆中KRAS突变检测的方法

2019-02-08

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Oncogene：Kras突变能够诱导的CD24表达上调能够增强前列腺癌的多能性和骨转移

2018-12-23

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CANCER RES：Refametinib联合Sorafenib治疗RAS突变肝细胞癌

2018-10-24

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

ANN ONCOL：转移性结直肠癌患者循环肿瘤DNA RAS突变分析

2018-06-08

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CHEM：多重检测胰腺导管腺癌患者游离DNA 中KRAS突变的预后意义

2018-04-06

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CANCER RES：乙酰水杨酸联合索拉非尼治疗RAS突变肿瘤

2018-03-09

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

EUR J Cancer：转移性结直肠癌治疗中，BRAF和RAS突变对一线疗法（FOLFIRI加西妥昔单抗，FOLFIRI加贝伐单抗）的影响

2018-01-01

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

EUR J Cancer：放疗联合卡培他滨和索拉非尼治疗晚期KRAS突变的直肠癌：I / II期临床试验（SAKK 41/08）

2017-12-26

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

Autophagy：RAS突变如何促进癌症发展

2017-12-26

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

张艳桥教授 | （K）RAS突变型晚期结直肠癌的治疗

2017-12-15

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

CLIN CANCER RES：WEE1和mTOR协同抑制治疗KRAS突变肺癌

2017-11-27

bioon7 (审核中...)

前往app查看评论内容

#RAS突变#

ANN SURG：解剖性切除可以改善KRAS突变结直肠癌肝转移患者无病生存

2017-09-30

科室
- - 订阅+
  - 更多科室
工具
服务